Skip to main content
Livermore
Livermore
ZHEN

Euclidean Capital LLC

SEC CIK
0001825034
Latest filing
Aug 14, 2026

ORIC holding history

Oric Pharmaceuticals, Inc. in every 13F filed by Euclidean Capital LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ORIC overviewAll 13F holders of ORICFull Q2 2026 holdings

Shares (Q2 2026)
989,410
Value
$10.7M
% of portfolio
2.4%
Quarters held
22
Since Q1 2021
Holdings of ORIC by Euclidean Capital LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026989,410$10.7M2.4%00.0%UnchangedHolders
Q1 2026989,410$12.5M3.2%00.0%UnchangedHolders
Q4 2025989,410$8.09M2.2%00.0%UnchangedHolders
Q3 2025989,410$11.9M5.0%00.0%UnchangedHolders
Q2 2025989,410$10.0M3.3%00.0%UnchangedHolders
Q1 2025989,410$5.52M2.1%00.0%UnchangedHolders
Q4 2024989,410$7.98M1.1%00.0%UnchangedHolders
Q3 2024989,410$10.1M1.1%00.0%UnchangedHolders
Q2 2024989,410$7.00M0.9%00.0%UnchangedHolders
Q1 2024989,410$13.6M1.7%00.0%UnchangedHolders
Q4 2023989,410$9.10M1.0%00.0%UnchangedHolders
Q3 2023989,410$5.99M1.3%+241,860+32.4%AddedHolders
Q2 2023747,550$5.80M1.5%00.0%UnchangedHolders
Q1 2023747,550$4.26M3.7%00.0%UnchangedHolders
Q4 2022747,550$4.40M4.1%00.0%UnchangedHolders
Q3 2022747,550$2.39M2.2%00.0%UnchangedHolders
Q2 2022747,550$3.35M2.8%00.0%UnchangedHolders
Q1 2022747,550$3.99M2.3%00.0%UnchangedHolders
Q4 2021747,550$11.0M6.2%−29,643−3.8%ReducedHolders
Q3 2021777,193$16.3M7.9%−219,541−22.0%ReducedHolders
Q2 2021996,734$17.6M5.7%00.0%UnchangedHolders
Q1 2021996,734$24.4M8.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.